Clinical Trials Browser

Bone Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Leukemia, Lymphoma, Melanoma, Sarcoma, Thyroid Neoplasms, Central Nervous System Neoplasms, Pyloric Stenosis, Hypertrophic

NCT06112613 2026-04-03

Mobile Health for Adherence in Breast Cancer Patients

Phase NA Recruiting

410 enrolled

Breast

Breast Neoplasms

NCT05076266 2026-04-02

COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation

Terminated

14 enrolled 10 charts

Breast

Breast Neoplasms

NCT02445391 2026-04-01

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Phase 3 Active not recruiting

415 enrolled 15 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00003140 2026-03-27

Letrozole After Tamoxifen in Treating Women With Breast Cancer

Phase 3 Completed

5,187 enrolled

Breast

Breast Neoplasms

NCT00066443 2026-03-27

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Phase 1/2 Completed

93 enrolled

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT03568422 2026-03-27

CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer

Phase 1/2 Active not recruiting

37 enrolled 14 charts

Breast

Breast Neoplasms

NCT05601440 2026-03-27

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

Phase 2 Recruiting

484 enrolled

Breast

Breast Neoplasms

NCT04316117 2026-03-23

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Phase 2 Active not recruiting

138 enrolled

Breast

Breast Neoplasms

NCT01349322 2026-03-05

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

Phase 3 Active not recruiting

2,354 enrolled 29 charts

Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT05896566 2026-02-24

PREcoopERA

Phase 2 Completed

231 enrolled

Breast

Breast Neoplasms

NCT07425002 2026-02-20

PRISM

Phase NA Recruiting

1,600 enrolled

Breast

Breast Neoplasms

NCT04176848 2026-02-18

CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer

Phase 2 Active not recruiting

15 enrolled 7 charts

Breast

Breast Neoplasms

NCT01674140 2026-02-10

e3

Phase 3 Active not recruiting

1,939 enrolled 15 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT02308085 2026-02-09

POSITIVE

Phase NA Active not recruiting

518 enrolled

Breast

Breast Neoplasms

NCT00066690 2026-02-06

SOFT

Phase 3 Completed

3,066 enrolled 15 charts

Breast

Breast Neoplasms

NCT00066703 2026-02-06

TEXT

Phase 3 Completed

2,672 enrolled 14 charts

Breast

Breast Neoplasms

NCT07380971 2026-02-02

Developing a Comprehensive Exercise Service for Breast Cancer Process

Recruiting

200 enrolled

Breast

Breast Neoplasms, Motor Activity

NCT03624543 2026-01-30

CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

Phase 2 Active not recruiting

51 enrolled

Breast

Breast Neoplasms

NCT06995443 2026-01-30

REGAIN

Phase NA Recruiting

200 enrolled

Breast

Breast Neoplasms, Neoplasms, Cognitive Dysfunction

Clinical Trials

TAILOR RT

3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast Cancer

Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer

The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer

FINER

Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Mobile Health for Adherence in Breast Cancer Patients

COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Letrozole After Tamoxifen in Treating Women With Breast Cancer

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

PREcoopERA

PRISM

CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer

e3

POSITIVE

SOFT

TEXT

Developing a Comprehensive Exercise Service for Breast Cancer Process

CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

REGAIN